Maintenance of telomere structure by the ribonucleoprotein enzyme telomerase is considered central to the development of most human cancers. However, regulatory mechanisms governing telomerase expression during oncogenesis are largely unknown. We address potential tumour-speci®c regulation of telomerase RNA gene expression by RNA in situ hybridization to over 300 tumour samples of germ cell and epithelial origin. Twenty-six per cent of non-small cell lung cancers (NSCLC), expressed detectable levels of the telomerase RNA gene (hTR), and interestingly expression was almost con®ned to squamous carcinomas (41%), being rare in pulmonary adenocarcinomas and large-cell anaplastic carcinomas (P=0.006). Low frequency hTR expression was also associated with adenocarcinoma of the breast (13%), and ovary (17%). In comparison, hTR expression was detected in 43% of cervical cancers with no signi®cant dierences in frequency between squamous-cell carcinoma and adenocarcinoma or in transitions between intraepithelial neoplasia and invasive carcinoma. In contrast to the common epithelial cancers, the malignant cells in 73% of testicular germ-cell tumours (seminomas and teratomas), expressed hTR consistent with hTR expression in normal testicular germ cells. Dierentiated tissues within ovarian germ cell tumours and in testicular teratomas lacked detectable hTR expression. These studies show that dierent tumour types have distinct patterns of hTR expression, which has implications for our understanding of mechanisms regulating telomerase activity and for targeting the telomerase RNA component as an anti-cancer therapy.
Introduction
Studies aimed at regulating genome stability to human cellular senescence have recently placed considerable emphasis on telomerase expression as a central unifying mechanism underlying the immortal phenotype of many cancers (Breslow et al., 1997) . Telomerase is a ribonucleoprotein which although thought to be required during development is largely repressed in adult somatic tissues Holt et al., 1996a; Morin, 1996; Shay and Wright, 1996; Villeponteau, 1996) . Telomerase replicates the terminal sequences of eukaryotic chromosomes, namely the telomeres (Morin, 1996) . The absence of telomerase activity from normal somatic cells has led to the proposal that telomere shortening may be a molecular clock which contributes to the onset of cellular senescence in normal cells Holt et al., 1996a) . Conversely, the reactivation or expression of telomerase may be a major mechanism by which cancer cells overcome normal cellular senescence (Kim et al., 1994; Parkinson et al., 1997) . Information on telomerase activity in tumours almost exclusively derives from the in vitro telomere repeat ampli®cation protocol (TRAP), and these have shown that telomerase activity may be present in greater than 80% of tumour biopsies yet absent or reduced in normal somatic tissue (Breslow et al., 1997; Kim et al., 1994; Raymond et al., 1996; Shay and Wright, 1996) . However, it is unlikely that TRAP assay alone will reveal the true complexities of telomerase regulation, and it is generally recognised that a number of molecular approaches will be required to understand telomere length regulation and telomerase activity (Breslow et al., 1997; Holt et al., 1996a; Lundblad and Wright, 1996; Parkinson et al., 1997; Raymond et al., 1996; Soder et al., 1997) . Recently, we and others have introduced a number of more direct in situ approaches to study the telomerase RNA gene (hTR) and its expression in tumours (Soder et al., 1997; Yashima et al., 1997) . Therefore, in order to gain insight into possible levels of telomerase regulation in vivo, we have examined over 300 tumours of epithelial and germ cell origin for hTR expression by in situ hybridization.
Results
The patterns of hTR expression were examined in epithelial cancer of lung, ovary, breast and cervix (Table 1) . Twenty-six per cent of non-small cell lung cancers (NSCLC), were hTR positive. However, the NSCLC group consists of squamous, adenocarcinoma and large-cell anaplastic variants. Interestingly however, expression was almost exclusively limited to the squamous variants (P=0.006), with 41% of squamous NSCLC expressing hTR but only 8% of adenocarcinoma and large-cell anaplastic NSCLC expressing hTR. These data suggest that hTR may be differentially regulated during the oncogenesis of squamous and non-squamous NSCLC. Indeed, the low frequency of detectable hTR expression in adenocarcinoma of the lung was also observed in adenocarcinoma of ovary and breast (Table 1 ). In addition, metastatic carcinoma in hilar lymph nodes of 19 of the NSCLC cases were available for a comparative study with the paired primary carcinomas. All six cases which expressed hTR in the primary carcinoma retained expression in the metastasis and all 13 primary carcinomas which lacked detectable hTR expression remained negative in the metastasis (Table 1) . Thus, expression levels appear stable between primary and metastatic carcinomas and expression of hTR is not associated with metastasis of pulmonary carcinomas.
Cancer of the uterine cervix is a heterogeneous group of lesions, which like NSCLC can be subdivided into squamous and adenocarcinoma (Benda, 1994) . We studied 87 cervical lesions for hTR expression (Table 1) . hTR expression was detected in 44% of the cervical carcinomas, however in contrast to NSCLC, there was no signi®cant dierence in frequency of expression between invasive squamous carcinoma (44%), and invasive adenocarcinoma (32%). The data for adenocarcinoma of the cervix also contrast those for invasive adenocarcinoma of the breast (13%), and ovary (17%) ( Table 1) , and suggest that regulation of hTR expression may be dierent for cervical cancer and therefore relate to the aetiology of the disease (Benda, 1994; Klingelhutz et al., 1996) . Interestingly, hTR expression was readily detected in preinvasive cervical cancer (40%, see Table  1 & Figure 1 ), and there was no signi®cant dierence in frequency between invasive and preinvasive lesions. In addition, the case of glandular intraepithelial neoplasia of the cervix shown in Figure 1 has heterogeneous expression of hTR, thus allowing the evolution of hTR expressing cells to be followed in their histological context. However, this example of heterogeneous hTR expression may also indicate potential problems with resistance to therapies targeting the RNA component of telomerase due to some cancer cells having low or undetectable levels of hTR expression.
Since telomerase activity should generally be present in normal male and female germ cells, it has been suggested that tumours arising from germ cells may have high levels of telomerase as a result of this normal tissue distribution (Burger et al., 1997; Hiyama et al., 1995a; Kim et al., 1994; Wright et al., 1996) . The primitive germ cells of the male are found in the seminiferous tubules and we examined 22 sections from normal testis and uninvolved tubules from testicular cancer patients to establish the pattern of hTR expression in normal seminiferous tubules ( Figure 1 ). Of the 22 sections, 21 showed hTR expression in the primitive germ cells located in the basal layers of the seminiferous epithelium (Table 1 ). The initimate relationship between germ cells and the supportive Sertoli cells, means that expression of hTR in the Sertoli cells cannot be excluded. Mature germ cells (spermatids and spermatazoa) when present, did not express hTR. Thus, the in situ assay can detect normal levels of hTR expression in primitive germ line stem cells and the distribution of hTR expression in the testis is consistent with its proposed role in the maintenance of telomere length in the germ line. A series of 22 testicular germ cell tumours were also analysed for hTR expression. As shown in Table 1 , 73% of testicular germ cell tumours were positive for hTR expression, and there was no signi®cant dierence between teratomas and seminomas of the To test for RNA integrity in the ovarian teratomas, a group of six were analysed for GAPDH expression and all were found to be positive. c A group of 33 NSLC were tested for histone H3 expression, 22 of which did not have detectable levels of hTR expression and all 33 were positive. An additional 4 hTR negative NSCLC samples tested for GAPDH expression were positive. d Two ovarian cancers (1 hTR negative), were tested for histone H3 expression and both were positive. Three ovarian cancers were tested for GAPDH expression and all were positive. e A group of 10 invasive breast cancers (7 hTR negative), were tested for histone H3 expression and all were positive. In addition, 11 breast cancers lacking detectable levels of hTR expression were tested and were positive for GAPDH expression.
f Four specimens of DCIS were obtained from patients who had in the previous 5 years been diagnosed and treated for the presence of preinvasive breast cancer (DCIS). The primary biopsies for all four were lacking detectable levels of hTR expression, however one recurrent DCIS biopsy had detectable hTR expression. Two cervical cancers (one lacking detectable levels of hTR expression), were tested for histone H3 expression and both were positive. Three cervical cancers were tested for GAPDH expression and all were positive. In total 28 samples (25 lacking detectable levels of hTR expression), were tested and were positive for GAPDH expression and 47 samples (31 lacking detectable levels of hTR expression) were tested and were positive for histone H3 expression. Visual inspection suggested that histone H3-positive cells were present in comparable numbers in the carcinomas lacking detectable levels of hTR expression and in the hTR positive carcinomas. The same areas of tissue were examined for both hTR and histone H3 expression, thus, the lack of detectable hTR expression is unlikely to be due simply to the presence of quiescent cells in the tumours (Holt et al., 1996b) .
testis. Interestingly, within hTR-positive teratomas, mature tissues never had detectable hTR expression whatever their dierentiation. Similarly, 15 benign ovarian teratomas composed of fully mature differentiated tissues had no detectable hTR expression (Table 1) . Thus, the dierentiated teratomas may recapitulate the down regulation of hTR during early embryonic or foetal development . In ®ve of the testicular seminomas there was no detectable hTR expression (Table 1) , but in each seminoma case, germ cells within adjacent normal seminiferous tubules expressed hTR, suggesting either that hTR expression has been repressed during oncogenesis, or that seminomas without detectable levels of hTR arise from germ cells with low or no hTR expression.
Discussion
We have examined over 300 tumours of germ cell and epithelial origin for hTR expression by in situ hybridization. This is the largest series of tumours to be examined and presented in a single study to date, for any aspect of telomere regulation in cancer progression. Thus, we have been able to address questions relating to the tumour-speci®c regulation of hTR expression during oncogenesis. We show that tumour speci®c patterns of hTR expression can be detected by in situ hybridization. These patterns may therefore relate to a combination of aetiological factors underlying carcinogenesis and tissue speci®c hTR gene regulation. For example, squamous cell carcinoma of the lung is much more clearly related to smoking than is adenocarcinoma of the lung, and these subtypes do dier signi®cantly in their patterns of hTR expression. Interestingly, Hiyama and colleagues (Hiyama et al., 1995b) , also observed a dierence in telomerase activity between adenocarcinoma and squamous non-small cell lung cancers. Thus the trend in tumour speci®c expression of telomerase activity in non-small cell lung cancers demonstrated by Hiyama (Hiyama et al., 1995b) is proven statistically for hTR expression in our study. On the other hand, both squamous and glandular carcinomas of the uterine cervix are exposed to the same carcinogenic in¯uences as far as is known, and both can express hTR suggesting that the carcinogenic insult such as papilloma virus may override tissue or dierentiation speci®c regulation of hTR (Klingelhutz et al., 1996) . These data will therefore be of value in analysing the relationship between molecular events occurring during oncogenesis and transcriptional activation of the telomerase RNA gene promoter, and in identifying the molecular controls on signal transduction resulting in telomerase activity (Soder et al., 1997; Villeponteau, 1996) . For hTR or telomerase to be useful biomarkers for disease or as a therapeutic target, dierential expression is required between normal and cancerous tissue (Breslow et al., 1997) . However, in both normal and cancerous tissue, admixture of cell types may confound interpretation of many assays. The in situ approach described here is ideally placed to solve this problem (Soder et al., 1997) . Indeed, the ease and reproducibility with which patterns of hTR expression can be assessed by in situ, suggests that hTR should be evaluated as a prognostic marker or as a biomarker for response to conventional therapies. NSCLC, cervical carcinoma or testicular germ cell cancer would be ideal for such an evaluation. In addition, the observation that hTR is readily detected in squamous and glandular intraepithelial cervical neoplasia oers opportunities for the early detection of preinvasive cervical neoplasia and to evaluate the relationship between expression and subsequent risk of developing invasive disease.
The application of the in vitro TRAP assay has been instrumental in furthering our knowledge of telomerase activity in cancer (Hiyama et al., 1996; 1995b) . Our present study suggests the in situ analysis of the essential telomerase RNA component detects tumourspeci®c patterns of expression not evident from TRAP assay studies to date. There may be a number of reasons for this including the sample size chosen for our study and the diversity in tumour pathologies analysed together. In addition, TRAP assays are exquisitely sensitive and may detect either very low levels or a few cells expressing telomerase within the tissue lysate making quantitative assessment dicult. In comparison, the RNA in situ assay may not detect low levels of telomerase RNA expression and thus introduce a level of discrimination. In any event, the biological relevance of low levels of telomerase or hTR expression are unknown. However, the advantage of an in situ approach is clearly seen in the cases of testicular seminoma in which the cancerous component did not have detectable levels of hTR expression yet the normal adjacent seminiferous tubules had hTR expression in the normal primitive germ cells. This situation would not have been resolved in a tissue homogenate assay. Indeed, the detection of hTR expression in 21 out of 22 normal germ cell samples suggests normal germ cells may be a relevant indicator of the sensitivity and reproducibility of the in situ approach, particularly since expression is con®ned to the normal primitive stem cells and not the mature spermatids.
It has been proposed that telomerase is an ideal anticancer target and initial reports suggest that inhibition of the telomerase RNA component will indeed cause cell death (Feng et al., 1995; Raymond et al., 1996; Villeponteau, 1996) . Successful development of telomerase inhibitors will require an understanding of hTR expression in all tumour types. Our studies point to examples of clear dierentials in expression between cancerous and adjacent normal tissue which support the possibility of eective telomerase-based therapy (Soder et al., 1997) . Indeed, the presence of high levels of hTR expression in speci®c cancers suggest the hTR promoter may be an interesting focus for genetic therapies designed to target therapeutic genes to tumours, via tumour speci®c gene expression. However, these therapeutic possibilities may be limited in those cancers like adenocarcinoma of the lung, breast and ovary in which relatively few cases express detectable levels of hTR.
Materials and methods

Preparation of tissue sections for in situ hybridization
Formalin ®xed paran embedded tissue blocks were obtained from Pathology Department ®les. Tissue sections were deparanized, rehydrated through graded concentrations of ethanol (100%, 90%, 70%, 50%, 30% EtOH, 10 sec each), rinsed in 0.85% sodium chloride for 5 min, followed by PBS for 5 min. Sections were ®xed in 4% paraformaldehyde/PBS for 20 min, rinsed in PBS, and treated with proteinase K (40 mg/ml) in 50 mM Tris-HCl pH 7.5, 5 mM EDTA for 7.5 min at room temperature. After rinsing for 5 min in PBS, sections were post ®xed in 4% paraformaldehyde/PBS for 5 min, rinsed in water, and acetylated in freshly prepared 0.25% acetic anhydride/ 0.1 M triethanolamine for 10 min. The slides were rinsed in 0.85% saline, followed by PBS for 5 min each and dehydrated in gradually increasing concentrations of ethanol prior to hybridization.
Probe preparation for in situ hybridization
The riboprobe plasmid containing telomerase RNA sequences used for RNA in situ hybridization is as previously described (Soder et al., 1997) . Control riboprobes were human histone H3 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Ambion, Texas, USA). The probes were labelled with 35 S-UTP using a RNA labelling kit (Amersham, UK). Transcripts were puri®ed using a Sephadex G-50 column (Pharmacia), phenol/chloroform extracted and precipitated in ethanol. The probes were resuspended in 50 mM dithiothreitol. Northern blot analysis of normal human tissue con®rmed the speci®city and sensitivity of the hTR probe to detect hTR expression in normal testis (data not shown).
Hybridization and washing procedures
Sections were hybridized overnight at 528C in 60% formamide, 0.3 M NaCl, 10 mM Tris-HCl (pH 7.5), 5 mM EDTA, 10% dextran sulphate, 16Denhardts (0.02% BSA, 0.02% Ficoll, 0.02% polyvinylpyrrolidone), 0.5 mg/ml yeast tRNA, 50 mM DTT (freshly added), and 50 000 c.p.m./ul 35 S-labelled cRNA probe. The tissue was washed stringently at 508C in 56SSC, 0.1% b-mercaptoethanol for 25 min, at 658C in 50% formamide, 26SSC, 1% b-mercaptoethanol for 25 min, and washed twice at 378C in 0.5 M NaCl, 10 mM Tris-HCl pH 7.5, 5 mM EDTA for 15 min before treatment with 20 mg/ml RNaseA at 378C for 30 min. RNaseA only digests single stranded RNA. This removes single stranded, and therefore unhybridized probe, leaving the RNA : RNA duplexes intact. Thus this step helps reduce background probe signal. Following washes in 50% formamide, 26SSC, 1% b-mercaptoethanol at 658C for 20 min, and twice in 26SSC at 508C for 15, the slides were dehydrated and dipped in 0.1% gelatine/0.01% chromealun, and then in Hypercoat Nuclear LM-1 emulsion (Amersham) and exposed for 2 weeks in light tight boxes with desiccant at 48C. The microautradiographs were developed in 20% Phenisol for 2.5 min, washed in 1% acetic and water each for 30 s, ®xed in 30% sodium thiosulphate for 5 min, rinsed in water 30 min, and counter-stained with haematoxylin.
Slide evaluation
Slides were evaluated as previously described (Soder et al., 1997) . Brie¯y, hybridizations were evaluated by three investigators (WNK, AIS and JJG). All samples were analysed at least twice and sections from dierent tumour groups analysed together in batches. Within all hybridizations, sections of lung tumours with known levels of hTR expression were included to ensure reproducibility and quality. Sections without detectable hTR expression as determined by hybridization to hTR sense and antisense probe were also included (Soder et al., 1997) . Positive signal was always nuclear localized (Soder et al., 1997) . Areas of normal tissue within each section also acted as a control.
Statistics
Dierences in hTR expression between tumour groups was analysed using the chi-square test with the a priori level of signi®cance set to P50.05.
